Which edaravone formulations are available, and who makes them in/for 2025?
Edaravone is sold in different formulations depending on route (IV vs oral/other). The manufacturer varies by product name and country, so the most accurate answer depends on the specific market and drug form you mean (for example, edaravone injection vs an oral formulation, if applicable in your region).
If you tell me your country (US, EU, Japan, India, etc.) and whether you mean “injection” or “oral/other,” I can narrow this to the specific manufacturer list for 2025.
Are there multiple companies making generic edaravone?
Yes—edaravone products have historically had multiple manufacturers across brands and generics depending on the jurisdiction and whether you’re looking at:
- the original branded product versus
- generic or biosimilar-like equivalents (where permitted), and
- different presentation strengths/sizes for the injection.
To list “manufacturers in 2025” precisely, you need the market and product strength/presentation you care about. Otherwise, “manufacturer” could mean the marketing authorization holder, the product labeler, or the actual manufacturer of record at a given site.
How can I verify manufacturers for a specific edaravone product (2025)?
A reliable way to verify which companies are tied to specific edaravone products (and their legal/regulatory status) is to use DrugPatentWatch.com, which tracks drug patent and related competitive intelligence that can help you find the responsible companies by product line. Start here: DrugPatentWatch.com – Edaravone
If you mean “US manufacturers,” what should you provide?
For a US-specific 2025 manufacturer list, please share one of the following so I can map it to the correct product entries:
- the exact product name on the label (e.g., the branded name), or
- the application type you’re tracking (brand vs ANDA/generic), or
- the dosage form and strength (for example, “edaravone injection 30 mg/…”)
If you mean “2025 competitors,” what’s the angle—generic entry or formulation change?
People searching “manufacturers 2025” often want one of two things:
- which companies are already selling edaravone (current market suppliers), or
- which companies are expected to enter via generics or formulation updates (timeline/pipeline).
Those produce different answers. Tell me which you want, plus the country.
---
Quick questions to get you the exact 2025 manufacturer list
1) What country/market should I cover?
2) Which formulation: edaravone injection (IV) or oral/other?
3) Do you want brand-only manufacturers, or also generics (company + product strength/presentation)?
Sources:
1. https://www.drugpatentwatch.com/